Impact of Familial and Hereditary Prostate Cancer on Cancer Specific Survival After Radical Retropubic Prostatectomy
Abstract
Purpose:
Men with a family history of prostate cancer are at higher risk for prostate cancer. There are conflicting data regarding the impact of hereditary forms of prostate cancer on long-term outcomes after radical prostatectomy. We examined the impact of familial and hereditary prostate cancer treatment in the prostate specific antigen era.
Materials and Methods:
Patients who underwent radical prostatectomy for prostate cancer from 1987 to 1997 were surveyed (3,560 responders) to determine the family history of prostate cancer. Patients were categorized as having familial prostate cancer if they had at least 1 first-degree relative with prostate cancer. Hereditary prostate cancer was defined as nuclear families with 3 cases of prostate cancer, families with prostate cancer in each of 3 generations and families with 2 men diagnosed before age 55 years. Sporadic prostate cancer was defined as patients with no family history. Clinical and pathological features, and long-term outcome measures, including biochemical recurrence-free, systemic progression-free and cancer specific survival, were compared among patients with familial, hereditary and sporadic prostate cancer.
Results:
A total of 865 and 133 patients were categorized as having familial prostate cancer and hereditary prostate cancer, respectively. Preoperatively prostate specific antigen was higher in patients with hereditary prostate cancer than in the other 2 groups (p = 0.04). Ten-year biochemical progression-free, systemic progression-free and cancer specific survival were equivalent.
Conclusions:
Except for preoperative prostate specific antigen, clinicopathological features and long-term oncological outcomes are equivalent after radical prostatectomy in patients with familial, hereditary and sporadic prostate cancer.
References
- 1 : A systematic review and meta-analysis of familial prostate cancer risk. BJU Int2003; 91: 789. Google Scholar
- 2 : Family history and prostate cancer risk in a population-based cohort of Iowa men. Cancer Epidemiol Biomarkers Prev1999; 8: 53. Google Scholar
- 3 : Relative risk of prostate cancer for men with affected relatives: systematic review and meta-analysis. Int J Cancer2003; 107: 797. Google Scholar
- 4 : Hereditary prostate cancer: clinical aspects. J Urol2002; 168: 906. Link, Google Scholar
- 5 : Where are the prostate cancer genes? A summary of eight genome wide searches. Prostate2003; 57: 261. Google Scholar
- 6 : Familial prostate cancer cases before and after radical prostatectomy do not show any aggressiveness compared with sporadic cases. Urology2003; 61: 1193. Google Scholar
- 7 : Significance of familial history of prostate cancer to traditional prognostic variables, genetic biomarkers, and recurrence after radical prostatectomy. Urology1998; 51: 970. Google Scholar
- 8 : Biological aggressiveness of hereditary prostate cancer: long-term evaluation following radical prostatectomy. J Urol1998; 160: 660. Link, Google Scholar
- 9 : Factors that influence the measurement of prostate cancer DNA ploidy and proliferation in paraffin embedded tissue evaluated by flow cytometry. Mod Pathol2001; 14: 906. Google Scholar
- 10 : Hereditary prostate cancer: epidemiologic and clinical features. J Urol1993; 150: 797. Link, Google Scholar
- 11 : Defining prostate specific antigen progression after radical prostatectomy: what is the most appropriate cut point?. J Urol2001; 165: 1146. Link, Google Scholar
- 12 : Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA1992; 89: 3367. Google Scholar
- 13 : Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science1996; 274: 1371. Google Scholar
- 14 : Characteristics of prostate cancer in families potentially linked to the hereditary prostate cancer 1 (HPC1) locus. JAMA1997; 278: 1251. Google Scholar
- 15 : Family history of prostate cancer in patients with localized prostate cancer: an independent predictor of treatment outcome. J Clin Oncol1997; 15: 1478. Google Scholar
- 16 : Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet1994; 343: 692. Google Scholar
- 17 : Cancer incidence in BRCA1 mutation carriers. J Natl Cancer Inst2002; 94: 1358. Google Scholar
- 18 Cancer risks in BRCA2 mutation carriers. Breast Cancer Linkage Consortium. J Natl Cancer Inst1999; 91: 1310. Google Scholar
- 19 : Variation in cancer risks, by mutation position, in BRCA2 mutation carriers. Am J Human Genet2001; 68: 410. Google Scholar
- 20 : Male BRCA1 and BRCA2 mutation carriers: a pilot study investigating medical characteristics of patients participating in a prostate cancer prevention clinic. Prostate2005; 65: 124. Google Scholar
